ADENYLYL CYCLASE BY ADENOSINE 3'-PHOSPHATES
3-磷酸腺苷产生腺苷酸环化酶
基本信息
- 批准号:6634929
- 负责人:
- 金额:$ 40.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-01 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:G protein X ray crystallography active sites adenosine monophosphate adenosine triphosphate adenylate cyclase affinity labeling biological signal transduction cell growth regulation chemical synthesis conformation cyclic AMP electron spin resonance spectroscopy enzyme inhibitors enzyme mechanism enzyme structure fluorescent dye /probe hormone regulation /control mechanism isozymes laboratory rat nuclear magnetic resonance spectroscopy nucleotide analog posttranslational modifications prodrugs tissue /cell culture
项目摘要
DESCRIPTION (Verbatim from Applicant's Abstract): Adenylyl cyclases are central
to one of the most important transmembrane signal transduction pathways in
virtually all biological systems and constitute a family of isozymes catalyzing
the formation of adenosine 3': 5'-monophosphate (cAMP) from 5'ATP. Mammalian
forms of the enzyme are stimulated or inhibited by hormones via
G-protein-linked cell-surface receptors and are inhibited by intracellular
adenine nucleoside 3'-phosphates via an enzyme conformation that is distinct
from that through which catalysis occurs. The proposal is based on observations
made with and unique applications for conformation-specific inhibitors of
adenylyl cyclases we have synthesized: a) competitive inhibitors targeting the
pre-transition, catalytically competent conformation, exemplified by
b-L-2',3'-dideoxyadenosine-5'-triphosphate (IC50 about 24nM), and b)
non-competitive inhibitors targeting the post-transition product leaving
conformation, exemplified by 2',5'-dideoxyadenosine-3'-triphosphate (IC50 about
40nM). The goals of the proposed investigations include: i) to use these
ligands and derivatives of them to define structural differences between pre-
and post-transition configurations of adenylyl cyclase and differences among
selected wild type and mutated adenylyl cyclase isozymes, by biochemical and
biophysical techniques; ii) to establish in intact cells and tissues the
consequences of adenylyl cyclase inhibition by prodrug derivatives of these
nucleotides; iii) to identify and quantify naturally occurring adenine
nucleoside 3'-polyphosphates and to identify the pathways of their synthesis
and degradation; and iv) to isolate other enzymes through which they may act to
alter cell function. The proposed approaches build on the applicant's
experience with adenylyl cyclases, with its regulation by adenine nucleotides,
and with the synthesis of unique, labeled and unlabeled nucleotide derivatives
targeted to specific configurations of this key transmembrane signal
transduction enzyme. The proposed studies will provide unique ligands and
approaches to address key questions regarding the structure and regulation of
adenylyl cyclases, will establish previously unexplored links between
cell-initiated regulation of adenylyl cyclases and 3'-nucleotide metabolism,
and will lead to the identification of other target proteins with which adenine
nucleoside 3'-polyphosphates interact and regulate.
描述(逐字研究来自申请人的摘要):腺苷酸循环酶是中心
到最重要的跨膜信号转导通路之一
几乎所有生物系统,构成同工酶催化的家族
腺苷3':5'ATP的形成5'ATP。哺乳动物
酶的形式被激素通过
G蛋白连接的细胞表面受体,细胞内抑制
腺嘌呤核苷3'-磷酸盐通过酶构象不同
由此通过催化。该提案基于观察
与特定于构象特异性抑制剂的独特应用
我们已经合成的腺苷酸循环酶:a)针对的竞争性抑制剂
预先过渡,催化胜任构象,例证了
B-l-2',3'-二氧添加性5'-三磷酸(IC50约24nm),B),B)
针对过渡后产品的非竞争性抑制剂离开
构象,以2',5'-二氧乙烯果碱-3'-triphosphate(关于IC50的IC50)为例
40nm)。拟议调查的目标包括:i)使用这些
它们的配体和衍生物是定义前的结构差异
和腺苷环酶的过渡后配置以及之间的差异
通过生化和
生物物理技术; ii)在完整的细胞和组织中建立
前药衍生物抑制腺苷酸环化酶的后果
核苷酸; iii)识别和量化天然存在的腺嘌呤
核苷3'-聚球并识别其合成的途径
和退化; iv)隔离其他酶,它们可以采取行动
改变单元功能。拟议的方法建立在申请人的基础上
具有腺苷循环酶的经验,并由腺嘌呤核苷酸调节,
并合成独特,标记和未标记的核苷酸衍生物
针对此关键跨膜信号的特定配置
转导酶。拟议的研究将提供独特的配体,并
解决有关结构和调节的关键问题的方法
adenylyl循环酶将建立以前未开发的链接
细胞引发的腺苷酸环酶和3'-核苷酸代谢的调节,
并将导致鉴定腺嘌呤的其他靶蛋白
核苷3'-聚磷酸盐相互作用并调节。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of adenylate cyclase by adenosine: characterization of the P-site.
腺苷对腺苷酸环化酶的调节:P 位点的表征。
- DOI:10.1042/bst0180150
- 发表时间:1990
- 期刊:
- 影响因子:3.9
- 作者:Bushfield,M;Johnson,RA
- 通讯作者:Johnson,RA
Purification, characterization, and N-terminal amino acid sequence of the adenylyl cyclase-activating protease from bovine sperm.
牛精子腺苷酸环化酶激活蛋白酶的纯化、表征和 N 端氨基酸序列。
- DOI:10.1095/biolreprod52.3.490
- 发表时间:1995
- 期刊:
- 影响因子:3.6
- 作者:Adeniran,AJ;Shoshani,I;Minuth,M;Awad,JA;Elce,JS;Johnson,RA
- 通讯作者:Johnson,RA
Determination of adenylyl cyclase catalytic activity using single and double column procedures.
使用单柱和双柱程序测定腺苷酸环化酶催化活性。
- DOI:10.1016/0076-6879(94)38005-8
- 发表时间:1994
- 期刊:
- 影响因子:0
- 作者:Johnson,RA;Alvarez,R;Salomon,Y
- 通讯作者:Salomon,Y
Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists.
聚腺苷酸和“P”位激动剂抑制百日咳博德特氏菌和炭疽芽孢杆菌腺苷酸环化酶。
- DOI:
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Johnson,RA;Shoshani,I
- 通讯作者:Shoshani,I
Irreversible inactivation of adenylyl cyclase by the "P"-site agonist 2',5'-dideoxy-,3'-p-fluorosulfonylbenzoyl adenosine.
“P”位点激动剂 2,5-二脱氧-,3-对氟磺酰基苯甲酰腺苷对腺苷酸环化酶产生不可逆失活。
- DOI:
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Yeung,SM;Johnson,RA
- 通讯作者:Johnson,RA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger A Johnson其他文献
Roger A Johnson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger A Johnson', 18)}}的其他基金
REGULATION OF ADENYLYL CYCLASE BY 3' ADENOSINE PHOSPHATE
3 磷酸腺苷对腺苷酸环化酶的调节
- 批准号:
2140690 - 财政年份:1986
- 资助金额:
$ 40.95万 - 项目类别:
REGULATION OF ADENYLYL CYCLASE BY 3' ADENOSINE PHOSPHATE
3 磷酸腺苷对腺苷酸环化酶的调节
- 批准号:
2900202 - 财政年份:1986
- 资助金额:
$ 40.95万 - 项目类别:
ADENYLYL CYCLASE BY ADENOSINE 3'-PHOSPHATES
腺苷 3-磷酸酯引起的腺苷酸环化酶
- 批准号:
6130991 - 财政年份:1986
- 资助金额:
$ 40.95万 - 项目类别:
REGULATION OF ADENYLYL CYCLASE BY 3' ADENOSINE PHOSPHATE
3 磷酸腺苷对腺苷酸环化酶的调节
- 批准号:
2140689 - 财政年份:1986
- 资助金额:
$ 40.95万 - 项目类别:
相似国自然基金
基于Brigatinib复合物结构指导的抗肺癌EGFR T790M/C797S新药设计与研发
- 批准号:81903539
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
IFP35和NMI的复合体结构及其分泌调控机制
- 批准号:31870739
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
新型铁电金属的显微结构及电子结构研究
- 批准号:51872034
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
金黄色葡萄球菌生物被膜相关蛋白的结构与功能研究
- 批准号:31872712
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
线粒体钙/氢转运体LETM1的结构解析和离子转运调控的分子机制研究
- 批准号:31870736
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
- 批准号:
10377400 - 财政年份:2020
- 资助金额:
$ 40.95万 - 项目类别:
Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
- 批准号:
10598482 - 财政年份:2020
- 资助金额:
$ 40.95万 - 项目类别: